Within the gene therapy community, frustration mounts as Capsida has yet to disclose which brain receptor was involved when the adverse event occurred, delaying progress in understanding the incident.
People are increasingly turning to AI as a way to ease the mental effort required for decision-making and problem-solving. While this reliance can be helpful, for some individuals it risks becoming an unhealthy dependence that diminishes their ability to think critically on their own.
Relying on a patchwork of state regulations for clinical AI won't ensure safe and consistent healthcare. Instead, a unified national framework is needed to license AI medical applications, ensuring they meet rigorous standards for patient safety and effectiveness. This approach balances innovation with accountability, paving the way for responsible deployment of AI in medicine.
An overview of critical developments in biotech, including a lawsuit surrounding a Duchenne muscular dystrophy therapy and the White House complications faced by FDA Commissioner Marty Makary, featured in The Readout.
In this edition of STAT Health Tech, we delve into a prominent study evaluating AI's ability to outperform doctors in diagnostic accuracy. Additionally, we explore how telehealth is influencing abortion access and review the ongoing lawsuit involving Epic Systems.
AstraZeneca is set to expand its research and development operations in the UK, benefiting from provisions in the latest US-UK trade agreement that aim to boost UK drug spending. This move underscores the positive impact of international trade deals on pharmaceutical investment and innovation in the region.
On Thursday, scientists reported in the journal Science the findings from a study evaluating an OpenAI model's capacity to perform diagnostic and clinical reasoning tasks. The results showcased impressive capabilities, prompting the scientific community to consider the implications and next steps for integrating AI in healthcare diagnostics.
A newly released report details notable progress in closing health disparities across various U.S. states from 2022 to 2024. Despite these encouraging developments, experts express concern that the gains may not be maintained long-term without sustained effort and policy support.
FDA Commissioner announced a groundbreaking shift in clinical trials: regulators will now monitor trial endpoints live via the cloud. This real-time insight promises to make the drug development process faster and more responsive.
In this STAT Health Tech issue, hospitals are unveiling their own chatbots as a response to ChatGPT's popularity. Additionally, the Medicare ACCESS pilot program is underway, aiming to improve care accessibility. Meanwhile, Utah advances its pioneering 'AI doctor' project, pushing the boundaries of artificial intelligence in healthcare.
